These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17891257)

  • 1. Rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine.
    Castro AP; Elkis H
    Braz J Psychiatry; 2007 Sep; 29(3):207-12. PubMed ID: 17891257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.
    Conley RR; Love RC; Kelly DL; Bartko JJ
    Am J Psychiatry; 1999 Jun; 156(6):863-8. PubMed ID: 10360124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of time to rehospitalization among schizophrenic patients discharged on typical antipsychotics, clozapine or risperidone.
    Lin CH; Lin SC; Chen MC; Wang SY
    J Chin Med Assoc; 2006 Jun; 69(6):264-9. PubMed ID: 16863012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine.
    Werneck AP; Hallak JC; Nakano E; Elkis H
    Psychiatry Res; 2011 Aug; 188(3):315-9. PubMed ID: 21596442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics.
    Rabinowitz J; Lichtenberg P; Kaplan Z; Mark M; Nahon D; Davidson M
    Am J Psychiatry; 2001 Feb; 158(2):266-9. PubMed ID: 11156809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rehospitalization risk with second-generation and depot antipsychotics.
    Conley RR; Kelly DL; Love RC; McMahon RP
    Ann Clin Psychiatry; 2003 Mar; 15(1):23-31. PubMed ID: 12839430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.
    Kim JH; Kim D; Marder SR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.
    Volavka J; Czobor P; Cooper TB; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA
    J Clin Psychiatry; 2004 Jan; 65(1):57-61. PubMed ID: 14744169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse in patients with schizophrenia: a comparison between risperidone and haloperidol.
    de Sena EP; Santos-Jesus R; Miranda-Scippa A; Quarantini Lde C; Oliveira IR
    Braz J Psychiatry; 2003 Oct; 25(4):220-3. PubMed ID: 15328547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
    Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
    Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.
    Chengappa KN; Sheth S; Brar JS; Parepally H; Marcus S; Gopalani A; Palmer A; Baker RW; Schooler NR
    J Clin Psychiatry; 1999 Jun; 60(6):373-8. PubMed ID: 10401915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
    Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
    Carlson CD; Cavazzoni PA; Berg PH; Wei H; Beasley CM; Kane JM
    J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
    Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
    Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol.
    Volavka J; Czobor P; Nolan K; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Lieberman JA
    J Clin Psychopharmacol; 2004 Apr; 24(2):225-8. PubMed ID: 15206671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.
    Scheltema Beduin AA; Swets M; Machielsen M; Korver N;
    J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
    Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M
    J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A naturalistic pilot study comparing haloperidol, clozapine, sertindole, and risperidone in partially responsive chronic schizophrenia or schizoaffective disorder.
    Fogelson DL; Sternbach H; Payne D
    J Clin Psychopharmacol; 1997 Dec; 17(6):492-4. PubMed ID: 9408817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.